Does erythropoietin augment noise induced hearing loss?

Hearing Research

Volumn 223, Issue 1-2, 2007, Pages 129-137

  Frederiksen, Birgitte Lidegaard ^a   Cayé Thomasen, Per ^a   Lund, Søren Peter ^b   Wagner, Niels ^a   Asal, Korhan ^a   Olsen, Niels Vidiendal ^c   Thomsen, Jens ^a  

^a GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^b NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

^c Mental Health Services CPH   (Denmark)

Author keywords

Auditory function; Blood flow; EPO; Guinea pigs; Inner ear; NIHL; Rats

Indexed keywords

EPOITIN ALPHA; ERYTHROPOIETIN; GLUTAMIC ACID; NITRIC OXIDE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CENTRAL NERVOUS SYSTEM; COCHLEA BLOOD FLOW; COCHLEA FENESTRA; CONTROLLED STUDY; DRUG EFFECT; DRUG INSTILLATION; ENVIRONMENTAL EXPOSURE; EVOKED BRAIN STEM AUDITORY RESPONSE; GUINEA PIG; HEARING; HEARING LOSS; HEMODYNAMICS; INNER EAR; MALE; MIDDLE EAR; NEUROPROTECTION; NOISE; NOISE INJURY; NONHUMAN; OTOACOUSTIC EMISSION; PRIORITY JOURNAL; RAT; RETINA INJURY; SINGLE DRUG DOSE; VASOCONSTRICTION; WIDE BAND NOISE;

ANIMALS; AUDITORY THRESHOLD; EPOETIN ALFA; EVOKED POTENTIALS, AUDITORY, BRAIN STEM; GUINEA PIGS; HEARING LOSS, NOISE-INDUCED; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; PERCEPTUAL DISTORTION; RATS; RATS, WISTAR;

EID: 33845651321     PISSN: 03785955     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.heares.2006.11.002     Document Type: Article

References (36)

1. Bode-Boger S.M., Boger R.H., Kuhn M., Radermacher J., and Frolich J.C. Recombinant human erythropoietin enhances vasoconstrictive tone via endothelin-1 and constrictor protanoids. Kidney Int. 50 (1996) 1255-1261
2. Brines M.L., Ghezzi P., Keenan S., Agnello D., de Lanerolle N.C., Cerami C., Itri M.L., and Cerami A. Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc. Natl. Acad. Sci., USA 97 (2000) 10526-10531
3. Buemi M., Cavallaro E., Floccari F., Sturiale A., Aloisi C., Trimarchi M., Corica F., and Frisina N. The pleiotropic effects of erythropoietin in the central nervous system. J. Neuropathol. Exp. Neurol. 62 (2003) 228-236
4. Cayé-Thomasen P., Wagner N., Lauréll G., Bagger-Sjöbäck D., and Thomsen J. An animal model for continous drug administration to the inner ear. Audiological Med. 2 (2004) 174-178
5. Cayé-Thomasen P., Wagner N., Frederiksen B.L., Asal K., and Thomsen J. Erythropoietin and erythropoietin receptor expression in the guinea pig inner ear. Hear. Res. 203 (2005) 21-27
6. Cerami A., Brines M., Ghezzi P., Cerami C., and Itri L.M. Neuroprotective properties of epoitin alfa. Nephrol. Dial. Transplant. Suppl 1 (2002) 8-12
7. Chattopadhyay A., Choudhury T.D., Bandyopadhyay D., and Datta A.G. Protective effect of erythropoietin on the oxidative damage of erythrocyte membrane by hydroxyl radical. Biochem. Pharmacol. 59 (2000) 419-425
8. Digicaylioglu M., and Lipton S.A. Erythropoietin-mediated neuroprotection involves cross-talk between JAK2 and NF-kappaB signaling cascades. Nature 412 (2001) 641-647
9. Duan M.L., Ulfendahl M., Laurell G., Counter A.S., Pyykkö I., Borg E., and Rosenhall U. Protection and treatment of sensorineural hearing disorders caused by exogenous factors: experimental findings and potential clinical application. Review. Hear. Res. 169 (2002) 169-178
10. Grimm C., Wenzel A., Groszer M., Mayser H., Seeliger M., Samardzija M., Bauer C., Gassman M., and Reme C.E. HIF-1 induced erythropoietin in the hypoxic retina protects against light-induced retinal degeneration. Nat. Med. 8 (2002) 718-724
11. Henderson D., Bielefeld E.C., Harris K.C., and Hu B.H. The role of oxidative stress in noise-induced hearing loss. Ear Hear. 27 (2006) 1-19
12. Ishikawa A., Suzuki K., and Fujita K. A preventive effect of a selective endothelin-A receptor antagonist, S-0139, on the erythropoietin-induced reduction of the renal cortical blood flow. Urol. Res. 27 (1999) 312-314
13. Johnson K.L., Carrasco V., Prazma J., Zdanski C.J., Durland W.F., and Pillsbury H.C. Role of nitric oxide in kainic acid-induced elevation of cochlear compound action potential thresholds. Acta Otolaryngol. 118 5 (1998) 660-665
14. Junk A.K., Mammis A., Savitz S.I., Singh M., Roth S., Malhotra S., Rosenbaum P.S., Cerami A., Brines M., and Rosenbaum D.M. Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc. Natl. Acad. Sci. USA 99 (2002) 10659-10664
15. Juul S. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage. Acta Pædiatr. Suppl 438 (2002) 36-42
16. Juul S.E., Anderson D.K., Li Y., and Christensen R.D. Erythropoietin and erythropoietin receptor in the developing human central nervous system. Pediatr. Res. 43 (1998) 40
17. Kawakami M., Sekiguchi M., Sato K., Kozaki S., and Takahashi M. Erythropoietin receptor-mediated inhibition of exocytotic glutamate release confers neuroprotection during chemical ischemia. J. Biol. Chem. 276 (2001) 39469-39475
18. Latoni J., Shivapuja B., Seidman M.D., and Quirk W.S. Pentoxifylline maintains cochlear microcirculation and attenuates temporary threshold shifts following acoustic overstimulation. Acta Otolaryngol. 116 (1996) 388-394
19. 2+ channels: activation by phospholipase C-gamma 1. Kidney Int. 53 (1998) 1259-1268
20. Marti H.H., Bernaudin M., Petit E., and Bauer C. Neuroprotection and angiogenesis: dual role of erythropoietin in brain ischemia. News Physiol. Sci. 15 (2000) 225-229
21. Miller J.M., Brown J.N., and Schacht J. 8-Iso-prostaglandin F-2-alfa, a product of noise exposure, reduces inner ear blood flow. Audiol. Neurotol. 8 (2003) 207-221
22. 2+ mobilization and contraction in rat mesangial and aortic smooth muscle cultures. Exp. Hematol. 24 (1996) 392-397
23. Morishita E., Masuda S., Nagao M., Yasuda Y., and Sasaki R. Erythropoietin receptor is expressed in rat hippocampal and cerebral cortical neurons, and erythropoietin prevents in vitro glutamate-induced neuronal death. Neuroscience 76 (1997) 105-116
24. Puel J.L. Chemical synaptic transmission in the cochlea. Prog. Neurobiol. 47 6 (1995) 449-476
25. Quirk W.S., and Seidman D.S. Cochlear vascular changes on response to loud noise. Am. J. Otol. 16 (1995) 322-325
26. Rasmussen A.N., Osterhammel P.A., Lund S.P., Kristiansen G.B., and Andersen S. A system for measuring distortion product otoacoustic emissions at ultra-sonic frequencies in rodents. Int. J. Audiol. 44 (2005) 237-243
27. Renzi M.J., Farrell F.X., Bittner A., Galindo J.E., Morton M.T., Trinh H., and Jolliffe L.K. Erythropoietin induces changes in gene expression in pc-12 cells. Mol. Brain Res. 104 (2002) 86-95
28. Sanaka M., Wen T.-C., Matsuda S., Masuda S., Morishita E., Nagao M., and Sasaki R. In vivo evidence that erythropietin protects neurons from ischemic damage. Proc. Natl. Acad. Sci., USA 95 (1998) 4635-4640
29. Sasaki R. Pleiotropic functions of erythropoietin. Int. Med. 42 (2003) 142-149
30. Sasaki R., Masuda S., and Nagao M. Pleiotropic functions and tissue-specific expression of erythropoietin. News Physiol. Sci. 16 (2001) 110-113
31. 2+ mobilization and vasocontriction by ET(A) receptors in the gerbil spiral modiolar artery. J. Membr. Biol. 182 (2001) 183-191
32. Shingo T., Sorokan T., Shimazaki T., and Weiss S. Erythropoietin regulates the in vitro and in vivo production of neuronal progenitors by mammalian forebrain neural stem cells. J. Neurosci. 21 (2001) 9733-9743
33. Sirén A.-L., and Ehrenreich H. Erythropoietin - a novel concept for neuroprotection. Eur. Arch. Psychiatr. Clin. Neurosci. 251 (2001) 179-184
34. Springborg J.B., Ma X., Rochat P., Knudsen G.M., Amtorp O., Paulson O.B., Juhler M., and Olsen N.V. A single subcutaneous bolus of erythropoietin normalizes cerebral blood flow autoregulation after subarachnoid haemorrhage in rats. Br. J. Pharmacol. 135 (2002) 823-829
35. Umemure K., Asai Y., Uematsu T., and Nakashima M. Role of thromboxane A2 in a microcirculation disorder of the rat inner ear. Eur. Arch. Otorhinolaryngol. 250 (1993) 342-344
36. Wu X.C., Richards N.T., and Johns E.J. The influence of erythropoietin on the vascular responses of rat resistance arteries. Exp. Physiol. 84 (1999) 917-927